Table 1.
Epidemiological and clinical characteristics of confirmed COVID-19 cases
| Variables | All patients (n = 6635) | |
|---|---|---|
| Total | Percentage (%) | |
| Clinical symptoms | ||
| Fever | 5325 | 80.3 |
| Cough | 4262 | 64.2 |
| Fatigue/Myalgia | 2422 | 36.5 |
| Sputum | 1671 | 25.2 |
| Shortness of breath | 1187 | 17.9 |
| Headache/dizziness | 859 | 12.9 |
| Sore throat | 635 | 9.6 |
| Diarrhea | 627 | 9.4 |
| Chills | 477 | 7.2 |
| Nausea/Vomiting | 343 | 5.2 |
| Nasal congestion | 209 | 3.1 |
| Loss of appetite | 132 | 2.0 |
| Rhinorrhea | 75 | 1.1 |
| Chest pain | 60 | 0.9 |
| Hemoptysis | 37 | 0.56 |
| Impaired consciousness | 25 | 0.38 |
| Rigors | 24 | 0.36 |
| Conjunctival congestion | 19 | 0.29 |
| Impaired taste | 12 | 0.18 |
| Impaired smell | 12 | 0.18 |
| Impaired vision | 3 | 0.05 |
| Ataxia | 1 | 0.02 |
| Seizures | 1 | 0.02 |
| Imaging findings | ||
| Computed tomography (CT) findings | 1655 | 24 |
| Comorbidities | ||
| Hypertension | 1504 | 22.67 |
| Diabetes mellitus | 848 | 12.78 |
| Cigarette smoking | 309 | 4.66 |
| Cardiovascular disease | 254 | 3.83 |
| Pulmonary disease | 170 | 2.56 |
| Cerebrovascular disease | 73 | 1.10 |
| Malignancy | 70 | 1.06 |
| Chronic kidney disease | 66 | 0.99 |
| Gastrointestinal disease | 53 | 0.79 |
| Hepatitis B | 51 | 0.77 |
| Immunosuppression | 15 | 0.23 |
| Obstructive sleep apnea | 11 | 0.17 |
| HIV infection | 3 | 0.05 |
| Alcohol consumption | 2 | 0.03 |
| Organ transplant | 2 | 0.03 |